NCT07058688View on ClinicalTrials.gov

A Study of NTRX-07 in Participants With Alzheimer's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Interventions
DRUG

NTRX-07

Orally administered CB2 agonist

DRUG

Placebo

Inactive matched comparator

Trial Locations (6)

1083

NOT_YET_RECRUITING

Semmelweis University, Budapest

1145

NOT_YET_RECRUITING

Semmelweis University, Budapest

628 00

RECRUITING

Neuro Health Centrum s.r.o., Brno

160 00

RECRUITING

Neuropsychiatrie s.r.o., Prague

30-688

RECRUITING

Szpital Uniwersytecki W Krakowie, Krakow

53-659

RECRUITING

Wrocławskie Centrum Alzheimerowskie, Wroclaw

Sponsors

Collaborators (1)

Firalis SA
All Listed Sponsors
collaborator

Cruint Global Consulting Pte Ltd

UNKNOWN

collaborator

Firalis SA

INDUSTRY

collaborator

Pharma-Regist Kft.

UNKNOWN

lead

NeuroTherapia, Inc.

INDUSTRY

NCT07058688 - A Study of NTRX-07 in Participants With Alzheimer's Disease | Biotech Hunter | Biotech Hunter